Anticonvulsant and glutamate release-inhibiting properties of the highly potent metabotropic glutamate receptor agonist (2S,2′R,3′R)-2-(2′,3′-dicarboxycyclopropyl)glycine (DCG-IV)
- 14 September 1998
- journal article
- Published by Elsevier in Brain Research
- Vol. 805 (1-2) , 138-143
- https://doi.org/10.1016/s0006-8993(98)00698-2
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Specific group II metabotropic glutamate receptor activation inhibits the development of kindled epilepsy in ratsBrain Research, 1998
- Anti-epileptogenic and anticonvulsant activity of l-2-amino-4-phosphonobutyrate, a presynaptic glutamate receptor agonistBrain Research, 1997
- The Neuroprotective Activity of Group-II Metabotropic Glutamate Receptors Requires New Protein Synthesis and Involves a Glial–Neuronal SignalingJournal of Neuroscience, 1997
- DCG‐IV Selectively Attenuates Rapidly Triggered NMDA‐induced Neurotoxicity in Cortical NeuronsEuropean Journal of Neuroscience, 1996
- Metabotropic glutamate receptor modulation of voltage-gated Ca2+ channels involves multiple receptor subtypes in cortical neuronsJournal of Neuroscience, 1996
- Glutamate, GABA and epilepsyProgress in Neurobiology, 1995
- Blockade of both epileptogenesis and glutamate release by (1S,3S)-ACPD, a presynaptic glutamate receptor agonistBrain Research, 1995
- Activation of Class II or III Metabotropic Glutamate Receptors Protects Cultured Cortical Neurons Against Excitotoxic DegenerationEuropean Journal of Neuroscience, 1995
- Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal deathEuropean Journal of Pharmacology, 1994
- Inhibition of the development of electrical kindling of the prepyriform cortex by daily focal injections of excitatory amino acid antagonistsEuropean Journal of Pharmacology, 1988